Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in paediatric subjects: An analysis by age group

Keyphrases

• Aprepitant 100%
• Chemotherapy-induced Nausea 100%
• Age Groups 100%
• Pediatric Subjects 100%
• High-dose Chemotherapy 37%
• Complete Response 37%
• Ondansetron 25%
• Age Categories 25%
• Delayed Phase 25%
• Adverse Events 12%
• Phase II Study 12%
• All Ages 12%
• Placebo 12%
• Subgroup Analysis 12%
• Complete Response Rate 12%
• Moderate Risk 12%
• Emesis 12%

Nursing and Health Professions

• Chemotherapy Induced Nausea and Vomiting 100%
• Aprepitant 100%
• Dexamethasone 50%
• Age Groups 25%
• Zofran 25%
• Adverse Event 12%
• Chemotherapy 12%
• Placebo 12%
• Vomiting 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Aprepitant 100%
• Chemotherapy Induced Nausea and Vomiting 100%
• Dexamethasone 50%
• Chemotherapy 37%
• Zofran 25%
• Adverse Event 12%
• Placebo 12%
• Vomiting 12%